Liver Cancer PDQ®

In brief

Comprehensive clinical reference from NCI covering diagnosis, staging, and treatment protocols for childhood liver cancers including hepatoblastoma and hepatocellular carcinoma. Provides evidence-based guidance for oncology professionals managing pediatric liver malignancies.

• Childhood liver cancer is rare, with hepatoblastoma being the most common primary liver malignancy in pediatric patients
• Treatment typically involves surgical resection combined with chemotherapy, with outcomes dependent on tumor stage and resectability
• Alpha-fetoprotein (AFP) serves as a key tumor marker for diagnosis, monitoring treatment response, and surveillance for recurrence

Written by the GCMD Library team from the guideline.